Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10709 publications
The efficacy of varying doses of venetoclax combined with azacitidine for newly diagnosed adult acute myeloid leukemia in real-world settings: a single-center retrospective analysis.
Journal: Hematology (Amsterdam, Netherlands)
Published: October 14, 2025
Dual Regulation of DNA Methylation Orchestrates the Saline-Alkali Stress Response in Salt-Tolerant Brassica napus.
Journal: Journal of agricultural and food chemistry
Published: October 09, 2025
Decitabine-induced DNA methylation remodeling reveals targetable biological processes in gilthead seabream pituitary and liver explants.
Journal: Epigenetics
Published: October 07, 2025
Evaluating quality-of-life outcomes during decitabine therapy in older adults with acute myeloid leukemia: overview of reported studies and assessment instruments.
Journal: Expert review of hematology
Published: October 02, 2025
Management of MDS according to risk classifications
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Recent insights and clinical issues in acute myeloid leukemia in older adults
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Effects of DNA Methylation Inhibitors on Molecular and Structural Changes in Chromatin Organization in Leukemia Cells.
Journal: Molecular and cellular biology
Published: September 29, 2025
USP5 inhibition enables potential therapy for t(8;21) AML through ubiquitin-mediated AML1-ETO degradation in patient-derived xenografts.
Journal: Science translational medicine
Published: September 24, 2025
Clinical Efficacy of CAG Regimen Combined with Venetoclax, Chidamide, and Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: September 11, 2025
PD-1 Inhibitor Combined with Azacitidine and HAG Regimen for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia: A Prospective, Single-Arm, Phase II Clinical Study
Journal: Zhongguo shi yan xue ye xue za zhi
Published: September 11, 2025
Primary Acute Myeloid Leukemia with Concomitant BCR∷ABL and NPM1 Mutation.
Journal: Clinical laboratory
Published: September 09, 2025
Last Updated: 10/31/2025